triazoles has been researched along with Nerve Degeneration in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matharasala, G; Perumal, Y; Samala, G | 1 |
| Canas, PM; Cunha, GM; Cunha, RA; Machado, NJ; Oliveira, CR; Oliveira, JM; Porciúncula, LO; Silva, CG | 1 |
| Cristalli, G; Morelli, M; Pinna, A; Pontis, S; Schintu, N; Simola, N; Tronci, E; Volpini, R | 1 |
| Borsini, F; Frau, L; Khairnar, AS; Morelli, M; Schintu, N; Wardas, J | 1 |
| Amorim, RP; de Oliveira, DM; Fernandes, MJ; Nehlig, A; Persike, DS; Rosim, FE | 1 |
| Disteldorf, E; Jarry, H; Lehan, N; Mares, U; Rune, GM; von Lossow, R; Wehrenberg, U; Zhou, L | 1 |
| Dexter, DT; Dhankot, A; Gillies, GE; McArthur, S; Murray, HE | 1 |
| Behan, WM; Stone, TW | 1 |
8 other study(ies) available for triazoles and Nerve Degeneration
| Article | Year |
|---|---|
MG17, A Novel Triazole Derivative Abrogated Neuroinflammation and Related Neurodegenerative Symptoms in Rodents.
Topics: Animals; Brain; Carrageenan; Cell Survival; Diabetic Neuropathies; Edema; Inflammation; Inhibitory Concentration 50; Male; Mice; Motor Activity; Nerve Degeneration; Rats, Wistar; rho-Associated Kinases; RNA, Messenger; Triazoles | 2018 |
Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Caffeine; Cell Survival; Cells, Cultured; Down-Regulation; Male; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neuroprotective Agents; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphodiesterase Inhibitors; Phosphorylation; Presynaptic Terminals; Pyrimidines; Rats; Rats, Wistar; Receptor, Adenosine A2A; Synaptic Membranes; Triazoles | 2009 |
A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Brain Chemistry; CD11b Antigen; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Early Growth Response Protein 1; Gene Expression Regulation; Jaw; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Movement; Nerve Degeneration; Nerve Tissue Proteins; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Psychomotor Performance; Pyrimidines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rotarod Performance Test; Time Factors; Triazoles; Vibrissae | 2010 |
Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
Topics: Adenine; Adenosine A2 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Brain; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Triazoles | 2011 |
Differential neuroprotection by A(1) receptor activation and A(2A) receptor inhibition following pilocarpine-induced status epilepticus.
Topics: Adenosine; Analysis of Variance; Animals; Brain; Cell Count; Disease Models, Animal; Drug Interactions; Fluoresceins; Male; Nerve Degeneration; Neuroprotective Agents; Organic Chemicals; Phenylisopropyladenosine; Pilocarpine; Pyrimidines; Rats; Rats, Wistar; Reaction Time; Receptor, Adenosine A1; Receptor, Adenosine A2A; Status Epilepticus; Triazoles | 2011 |
Neuroprotection by estradiol: a role of aromatase against spine synapse loss after blockade of GABA(A) receptors.
Topics: Animals; Aromatase; Cells, Cultured; Dendritic Spines; Down-Regulation; Enzyme Inhibitors; Epilepsy; Estradiol; GABA Antagonists; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hippocampus; Letrozole; Nerve Degeneration; Neural Inhibition; Neuroprotective Agents; Nitriles; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, GABA-A; Synaptic Transmission; Triazoles | 2007 |
Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
Topics: Anastrozole; Animals; Aromatase; Aromatase Inhibitors; Cell Survival; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drug Resistance; Estrogens; Female; Male; Nerve Degeneration; Neural Pathways; Neuronal Plasticity; Neurotoxins; Nitriles; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Sex Characteristics; Substantia Nigra; Triazoles | 2007 |
Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist.
Topics: Adenosine A2 Receptor Antagonists; Animals; Brain Injuries; Brain Ischemia; Cytoprotection; Drug Synergism; Hippocampus; Interleukin-1beta; Male; Nerve Degeneration; Neuroprotective Agents; Neurotoxins; Pyramidal Cells; Quinolinic Acid; Rats; Rats, Wistar; Receptor, Adenosine A2A; Triazines; Triazoles; Tumor Necrosis Factor-alpha | 2007 |